Evidence map›Paper›PMID 39378078›Full record

ArticleInteractive journal of medical research2024

Predictive Value of Physiological Values and Symptom Scores for Exacerbations in Bronchiectasis and Chronic Obstructive Pulmonary Disease With Frequent Exacerbations: Longitudinal Observational Cohort Study.

Thomas Llewelyn Jones, Claire Roberts, Scott Elliott, Sharon Glaysher, Ben Green, Janis K Shute, Anoop J Chauhan

Abstract read
In one paragraph

Article in Interactive journal of medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thomas Llewelyn JonesDepartment of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0002-6324-7540
Claire RobertsDepartment of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0001-9878-7638
Scott ElliottTranslational Research Laboratory, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0003-4885-2432
Sharon GlaysherTranslational Research Laboratory, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0002-9584-0621
Ben GreenDepartment of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0002-5292-8375
Janis K ShuteSchool of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0002-6586-7583
Anoop J ChauhanDepartment of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.ORCID https://orcid.org/0000-0003-4044-6114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOPD (chronic obstructive pulmonary disease) and bronchiectasis are common, and exacerbations contribute to their morbidity and mortality. Predictive factors for the frequency of future exacerbations include previous exacerbation frequency and airway colonization. Earlier treatment of exacerbations is likely to reduce severity.

objectiveThis study tested the hypothesis that, in a population with bronchiectasis, COPD, or both who have frequent exacerbations and airway colonization, changes in symptom scores or physiological variables within 10 days prior to an exacerbation would allow the prediction of the event.

methodsWe performed a 6-month, longitudinal, observational, cohort study among 30 participants with bronchiectasis, COPD, or both; at least 2 exacerbations per year; and colonization with Pseudomonas aeruginosa or Haemophilus influenzae. Daily symptom and physiological data were collected, comprising pulse rate, blood pressure, oxygen saturation, peak flow rate, step count, weight, and temperature. Exacerbations (defined as the onset of new antibiotic use for respiratory symptoms) were collected, and predictive values for abnormal values in the 10 days prior to an exacerbation were calculated.

resultsA total of 30 participants were recruited, collecting a total of 39,534 physiological and 25,334 symptom data points across 5358 participant-days; these included 78 exacerbations across 27 participants, with the remaining 3 participants not having exacerbations within the 6-month observation period. Peak flow rate, oxygen saturation, and weight were significantly different at the point of exacerbation (all P<.001), but no significant trends around exacerbation were noted and no clinically beneficial predictive value was found in the overall or individually adjusted model. Symptom scores tended to worsen for 10 days on either side of an exacerbation but were of insufficient magnitude for prediction, with area under the receiver operating characteristic curve values of ranging from 0.4 to 0.6.

conclusionsWithin this small cohort with bronchiectasis, COPD, or both and airway colonization, physiological and symptom variables did not show sufficient predictive value for exacerbations to be of clinical utility. The self-management education provided as standard of care may be superior to either of these approaches, but benefit in another or larger cohort cannot be excluded. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/resprot.6636.

Indexed as

airway diseasebronchiectasischronic obstructive pulmonary diseaseCOPDpredictive modelssymptom score

Identifiers

PMID39378078
PMCPMC11496917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.